Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Flack

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
Journal of the American Heart Association|July 8, 2023
Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-AnalysisTariq Jamal Siddiqi, Muhammad Shariq Usman, Ahmed Mustafa Rashid, et al.
The American Journal of Emergency Medicine|June 20, 2015
Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohortPhillip D Levy, James J Mahn, Joseph Miller, et al.
Journal of the American Society of Hypertension : JASH|April 15, 2014
Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart diseaseMichael J Burla, Aaron M Brody, Brian A Ference, et al.
Lancet (London, England)|November 10, 2022
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P Schlaich, Marc Bellet, Michael A Weber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophyCesar A Romero, Shobi Mathew, Benjamin Wasinski, et al.
Ethnicity & Disease|November 8, 2007
Advancing the science of health disparities researchNancy T Artinian, Richard B Warnecke, Kimberly M Kelly, et al.
American Journal of Hypertension|July 5, 2020
Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart DiseasePhillip D Levy, Michael J Burla, Michael J Twiner, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Circulation|March 17, 2005
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing GroupEmelia J Benjamin, Mariell Jessup, John M Flack, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Aprocitentan for Blood Pressure Reduction in Black PatientsJohn M Flack, Markus P Schlaich, Michael A Weber, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Journal of the American Heart Association|July 8, 2023
Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-AnalysisTariq Jamal Siddiqi, Muhammad Shariq Usman, Ahmed Mustafa Rashid, et al.
The American Journal of Emergency Medicine|June 20, 2015
Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohortPhillip D Levy, James J Mahn, Joseph Miller, et al.
Journal of the American Society of Hypertension : JASH|April 15, 2014
Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart diseaseMichael J Burla, Aaron M Brody, Brian A Ference, et al.
Lancet (London, England)|November 10, 2022
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P Schlaich, Marc Bellet, Michael A Weber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophyCesar A Romero, Shobi Mathew, Benjamin Wasinski, et al.
Ethnicity & Disease|November 8, 2007
Advancing the science of health disparities researchNancy T Artinian, Richard B Warnecke, Kimberly M Kelly, et al.
American Journal of Hypertension|July 5, 2020
Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart DiseasePhillip D Levy, Michael J Burla, Michael J Twiner, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Circulation|March 17, 2005
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing GroupEmelia J Benjamin, Mariell Jessup, John M Flack, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Aprocitentan for Blood Pressure Reduction in Black PatientsJohn M Flack, Markus P Schlaich, Michael A Weber, et al.
Pageof 16